We are live on ! Find out more
SPHS

Sophiris Bio, Inc.
SPHS

Delisted

SPHS was delisted on the 11th of March, 2020.

18 hedge funds and large institutions have $732K invested in Sophiris Bio, Inc. in 2015 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

13% more funds holding

Funds holding: 1618 (+2)

33% less capital invested

Capital invested by funds: $1.09M → $732K (-$355K)

Holders
18
Holders Change
+2
Holders Change %
+12.5%
% of All Funds
0.48%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
2
Reduced
Closed
5
Calls
Puts
Net Calls
Net Calls Change

SPHS Hedge Fund Activity: Q2 2015 in Review

18 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q2 2015, worth a combined $732K — down 33% from $1.09M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new SPHS positions and 5 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $30.2K. The largest seller was BVF Inc, exiting entirely with an estimated $614K sold.

  • 18 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q2 2015, up from 16 in Q1 2015.
  • Funds reported $732K of Sophiris Bio, Inc. stock for Q2 2015, down 33% quarter-over-quarter.
  • 7 funds opened new Sophiris Bio, Inc. positions in Q2 2015 and 5 closed out, a net change of +2 holders.
  • The largest Sophiris Bio, Inc. buyer in Q2 2015 was Renaissance Technologies, an estimated $30.2K added.
  • The largest Sophiris Bio, Inc. seller in Q2 2015 was BVF Inc, an estimated $614K sold.

Based on aggregated 13F filings for Q2 2015.